Assessment of tumor morphology and antigenicity following cryo-assisted lumpectomy for breast carcinomas

被引：0
|
作者：
Talwalkar, Sameer S. [1 ]
Chagpar, Anees B. [1 ]
Lear, Sheron [1 ]
Martin, Alvin W. [1 ]
Sahoo, Sunati [1 ]
机构：
[1] Univ Louisville, Louisville, KY 40292 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2006年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
105
引用
收藏
页码：660 / 660
页数：1
相关论文
共 35 条
  • [31] LIQUID-BASED MATERIAL FROM FINE NEEDLE ASPIRATES OF BREAST CARCINOMAS IS AN OPTIMAL PRE-PROCEDURAL HANDLING OF THE TUMOR CELLS AND OFFERS THE POSSIBILITY OF LONG TIME STORAGE WITHOUT SIGNIFICANT LOSS OF ANTIGENICITY OF ESTROGEN AND PROGESTERONE RECEPTORS
    Ebeltoft, K.
    Pedersen, M. K.
    Sauer, T.
    Karesen, R.
    [J]. ACTA CYTOLOGICA, 2010, 54 (03) : 442 - 442
  • [32] A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
    Frithiof, Henrik
    Aaltonen, Kristina
    Ryden, Lisa
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 7095 - 7103
  • [33] High Negative Predictive Value of FDG-PET/CT in Assessment of Tumor Response Following Radiation Treatment for Head-and-Neck Carcinomas: Long-term update
    Wang, D.
    Michel, M.
    Baruah, D.
    Bedi, M.
    Campbell, B.
    Massey, B.
    Wong, S.
    Schultz, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S521 - S521
  • [34] SPIE-AAPM-NCI BreastPathQ Challenge: an image analysis challenge for quantitative tumor cellularity assessment in breast cancer histology images following neoadjuvant treatment
    Petrick, Nicholas
    Akbar, Shazia
    Cha, Kenny H.
    Nofech-Mozes, Sharon
    Sahiner, Berkman
    Gavrielides, Marios A.
    Kalpathy-Cramer, Jayashree
    Drukker, Karen
    Martel, Anne L.
    [J]. JOURNAL OF MEDICAL IMAGING, 2021, 8 (03)
  • [35] Combined assessment of metabolic response and tumor infiltrating lymphocytes as a predictor of outcomes following neoadjuvant therapy for HER2-positive breast cancer: Results from the randomized PREDIX HER2 trial.
    Matikas, Alexios
    Johansson, Hemming
    Gryback, Per
    Bjohle, Judith
    Lekberg, Tobias
    Fredholm, Hanna
    Acs, Balazs
    Elinder, Ellinor
    Isaksson-Friman, Erika
    Agartz, Susanne
    Hellstrom, Mats
    Zerdes, Ioannis
    Hartman, Johan
    Bergh, Jonas C. S.
    Hatschek, Thomas
    Foukakis, Theodoros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
1234